miR-3188 was confirmed as a positive modulator of FOXO1 via qRT-PCR in NPC cells treated with Mock, FOXO1 or both FOXO1 and siFOXO1 (Fig. 6a). This evidence concerns the gene FOXO1 and nasopharyngeal carcinoma.